$ARQT
Arcutis Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Arcutis Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ARQT down today? It is at $26.40 (-2.98%), and our scanner flagged it 127 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARQT spikes, and full due diligence on ARQT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARQT 127 times in the last 30 days. Create a free account to track $ARQT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ARQT traded in the last session, Friday (last price and move above). Our scanner fired 16 unusual-volume and momentum alerts on ARQT on Friday, peaking at 48.8x its normal volume.
Likely catalystArcutis Biotherapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Welgus Howard G. Director | Sold (automatic/other) | -5K | sold 12% | 35K | $133K at $28.16 | Nov 16, 26 |
Welgus Howard G. Director | Other | 4K | added 12% | 39K | $27K at $6.52 | Nov 16, 26 |
Watanabe Todd Officer | Sold (automatic/other) | -144K 0.1% of company | sold 20% | 569K | n/a | Nov 13, 26 |
Matsuda Masaru Officer | Sold (automatic/other) | -40K 0.03% of company | sold 26% | 111K | $1.4M at $34.32 | Nov 4, 26 |
Matsuda Masaru Officer | Other | 40K 0.03% of company | added 36% | 151K | $146K at $3.64 | Nov 4, 26 |
Watanabe Todd Officer | Sold (automatic/other) | -4K | sold 0.6% | 713K | $139K at $31.86 | Nov 2, 26 |
Burnett Patrick Officer | Sold (automatic/other) | -943 | sold 0.8% | 117K | $30K at $31.86 | Nov 2, 26 |
Matsuda Masaru Officer | Sold (automatic/other) | -1K | sold 1.1% | 111K | $39K at $31.86 | Nov 2, 26 |
Scott Robert A Director | Acquired (grant/award) | +3K | n/a | 3K | n/a | Oct 23, 26 |
Welgus Howard G. Director | Sold (automatic/other) | -5K | sold 12% | 35K | $127K at $26.93 | Oct 15, 26 |
Welgus Howard G. Director | Other | 4K | added 11% | 40K | $27K at $6.52 | Oct 15, 26 |
Matsuda Masaru Officer | Sold (automatic/other) | -4K | sold 3.2% | 113K | $92K at $25.00 | Sep 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ARQT traded in the last session, Friday (last price and move above). Our scanner fired 16 unusual-volume and momentum alerts on ARQT on Friday, peaking at 48.8x its normal volume.
ARQT last traded at $26.40, down 2.98% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ARQT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARQT 127 times in the last 30 days.
ARQT (Arcutis Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.33B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARQT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARQT discussion
Sign in to ask a question or join the discussion.